« Back
Home /
Luseogliflozin

Luseogliflozin

Item no.	A13476-25
Manufacturer	Adooq
Amount	25mg
Category	Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	CAS-No: 898537-18-3
Similar products	898537-18-3
Available
Short Description	Luseogliflozin is an orally active second-generation sodium-glucose co-transporter 2 (SGLT2) inhibitor developed by Taisho Pharmaceutical for the treatment of patients with type 2 diabetes mellitus (T2DM).
Cas No	898537-18-3
Synonyms	TS 071, TS071, TS-71
Formula	C23H30O6S
Solubilty	DMSO
Purity	>98%
Chemical Name	D-Glucitol, 1, 5-dideoxy-1, 5-epithio-1-C-(5-((4-ethoxyphenyl)methyl)-2-methoxy-4-methylphenyl)-, (1S)-
M. Wt.	434, 55
SMILES	CCOC1=CC=C(C=C1)CC2=C(C=C(C(=C2)[C@ H]3[C@ @ H]([C@ H]([C@ @ H]([C@ H](S3)CO)O)O)O)OC)C
Storage	2 years at -20C

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 25mg

available

Delivery expected until 8/30/2024

Express Delivery: Save 9 days

Compare

Add to wishlist

Recommend by mail